- Investing Ideas
- /
- Chinese Pharmaceuticals & Biotech High Return On Equity, Low Debt
Chinese Pharmaceuticals & Biotech High Return On Equity, Low Debt
Results
4
Stocks with a return on equity of over 30% and a debt to equity ratio below 1.
4 companies
Shanghai Allist Pharmaceuticals
Market Cap: CN¥45.5b
A pharmaceutical company, engages in the research and development of tumor-targeted drugs in China.
688578
CN¥101.82
7D
-3.5%
1Y
79.2%
Tianjin Pharmaceutical Da Ren Tang Group
Market Cap: CN¥32.3b
Produces and sells traditional Chinese medicine, western medicine, and other products primarily in the People’s Republic of China.
600329
CN¥49.30
7D
7.9%
1Y
42.8%
Xiamen Amoytop Biotech
Market Cap: CN¥29.7b
Engages in research, development, production, and sale of recombinant protein drugs in China.
688278
CN¥76.36
7D
1.3%
1Y
-2.6%
Shenyang Xingqi PharmaceuticalLtd
Market Cap: CN¥18.5b
Engages in the research and development, production, and sale of ophthalmic medications in the People’s Republic of China.
300573
CN¥73.82
7D
-7.0%
1Y
10.2%